sherman matthew l  insider stock trading  openinsider sector all sectors group by sector aerospace agriculture automobile building business services chemical electrical energy fashion financial food  beverage fund healthcare household insurance machinery media metals mining other personal services real estate retail technology telecom transportation utility industry all industries group by industry insiders filings all purchases sales cik   address  sidney street cambridge ma   results links secyahoogooglefinviztradingviewstockchartsstocktwitsdownload csv tc stat stk ins fil d w m q h y avg sretswins filing date t date ticker issuerinc sector indindustry owner ost rel title t tval price l qty oc own h ry ry rm rm rw rw rd rd fd fw fm fm fm fy  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiemdd  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiesdd  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiesd  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiemdd  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiemdd  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiemdd  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiesdd  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiemdd  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiesdmd  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiesm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiesm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiemdd  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiemdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiemdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiemdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiemdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiemdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiemdd  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiemdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiemdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaoevpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiemdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiemdmm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiemdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesad  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiemdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiemdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiemdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiemdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiemdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiemdd  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiemdd  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiemdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiemdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiemdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesdm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesm  xlrnacceleron pharma incdehealthbioprdbiological products no diagsherman matthew lmaosvpchiesm dderivative transaction in filing usually option exercise mmultiple transactions in filing earliest reported transaction date and weighted average transaction price aamended filing eerror detected in filing s  salesale of securities on an exchange or to another person s  saleoesale of securities on an exchange or to another person after option exercise f  taxpayment of exercise price or tax liability using portion of securities received from the company p  purchasepurchase of securities on an exchange or from another person return to top contact copyright   openinsidercom all rights reserved matthew l sherman executive profile  biography  bloomberg july    am et insurance company overview of nas insurance services inc snapshotpeople  overviewboard memberscommittees executive profile matthew l sherman senior vice president of specialty reinsurance and programs division nas insurance services incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background mr matthew l sherman also known as matt has been senior vice president of specialty reinsurance and programs division at nas insurance services inc since september   mr sherman served as the chief operating officer of knightbrook insurance company he began his career with venbrook in  focusing on sales and marketing he has over  years of product and brand management experience in the medical and technology fields he is a member of the board of  directors of knightbrook he earned a bachelor of science degree in business administration at northwestern university as well as an mba from the anderson school of management at uclaread full background corporate headquarters  ventura boulevardencino california united statesphone fax  board members memberships directorknightbrook insurance company education bsba northwestern universitymba ucla anderson school of management other affiliations northwestern universityucla anderson school of managementknightbrook insurance company annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation there is no total compensation data available request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact nas insurance services inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close matthew l sherman  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors matthew l sherman check out list of companies and businesses related to matthew l sherman find out matthew l sherman address and contact details view other people related to matthew l sherman  coworkers colleagues companions etc address  sidney street cambridge  ma companies related to matthew l sherman cikcompany namepositioncompany addressacceleron pharma incevp  chief medical officer  sidney street cambridge pulmatrix incdirector  hayden avenue suite  lexington  matthew l sherman on the web persons related to matthew l sherman  acceleron pharma incnamepositioncityadvanced technology ventures vi lpbostonadvanced technology ventures viib lpbostonadvanced technology ventures viic lpbostonadvanced technology ventures vii lpbostonnoubar afeyancambridgeagtc advisors fund lpcambridgeagtc partners lpcambridgeevnin anthonycambridgeapplied genomic technology capital fund lpcambridgeatv alliance  lpbostonatv associates vi llcbostonatv associates vii llcbostonatv entrepreneurs vi lpbostonatv entrepreneurs vii lpbostongordon carlcambridgecelgene corp de owner summithabib j dableceo and president cambridgekania edcambridgekania edwincambridgekania jr edwincambridgesteven d ertelevp  chief operating officer cambridgeanthony b evnindirector new yorkflagship ventures management inccambridgegolumbeski georgecambridgejean georgedirector lexingtonjean georgedirector bostonjean georgedirector bostongeorge golumbeskicambridgecarl l gordonnew yorksamuel d isalysamuel d isalynew yorkseehra jasbircambridgegeorge jeancambridgeknopf johncambridgezakrzewski josephcambridgeedwin m kania jrcambridgeedwin m kania jrdirector cambridgeedwin m kania jrdirector cambridgeterrence c kearneydirector lake forestterrence c kearneydirector cambridgeterrence c kearneydirector cambridgemclaughlin kevincambridgejohn l knopfceo and president cambridgeravindra kumarsvp  chief scientific officer cambridgetom maniatisdirector cambridgesherman matthewcambridgethomas a mccourtdirector cambridgeterrance mcguiredirector walthamterrance mcguiredirector walthamterrance mcguiredirector walthamkevin f mclaughlinsvp cfo and treasurer walthamkevin f mclaughlinsvp cfo and treasurer cambridgefrancois naderdirector salt lake cityfrancois naderdirector cambridgenewcogen group inccambridgeorbimed advisors llc orbimed advisors llcnew yorkorbimed capital gp ii llcnew yorkorbimed capital ii llcnew yorkgage patcambridgecourossi petercambridgepolaris venture management co iv llc owner walthampolaris venture management co iv llc owner walthampolaris venture partners entrepreneurs fund iv lpwalthampolaris venture partners iv lpwalthamrichard f popsdirector cambridgerichard f popsdirector cambridgejohn d quiselsvp bus dev gc  secretary cambridgepops richardcambridgesteininger robertcambridgechristopher rovaldicambridgematthew l shermanevp  chief medical officer cambridgerobert j steininger iicambridgeertel stevencambridgemcguire terrancecambridgemcguire terrycambridgemaniatis tomcambridgevef management iv llcpalo altovenrock associates iv l ppalo altovenrock entrepreneurs fund iv l ppalo altovenrock management iv llcpalo altovenrock partners lppalo altovenrock partners management llcpalo altovale wyliecambridgejoseph s zakrzewskidirector somersetjoseph s zakrzewskidirector cambridgepersons related to matthew l sherman  pulmatrix incnamepositioncityakihisa akaodirector petalumaakao akihisasanta rosahojabr alimiceo and chief science officer santa rosaarch venture fund vii lpchicagoarch venture partners vii lpchicagoarch venture partners vii llcchicagoclinton bybeechicagorobert w clarkechief executive officer lexingtonrichard k conleydirector petalumarichard k conleydirector santa rosakeith crandellchicagohava davidlexingtonmaki davidlexingtonwilliam e dukechief financial officer lexingtonjonathan a flintwalthamgregory m frenchdirector petalumagregory m frenchdirector santa rosasteven gillisdirector seattlekurt gravesdirector cambridgefrench gregorysanta rosafrench gregorysanta rosasameer harishchief financial officer santa rosadavid l havachief scientific officer lexingtonmichael j higginsdirector cambridgealimi hojabrsanta rosaalimi hojabrsanta rosamark t iwickidirector marlboroughgraves kurtlexingtondavid makidirector lexingtonterrance mcguiredirector walthamhiggins michaellexingtonamit munshidirector bostonrobert nelsenoculus innovative sciences inc owner petaluma oculus innovative sciences incpetalumapolaris venture management co iv llcwalthampolaris venture management co v llcwalthampolaris venture partners entrepreneurs fund iv lpwalthampolaris venture partners entrepreneurs fund v lpwalthampolaris venture partners founders fund v lpwalthampolaris venture partners iv lpwalthampolaris venture partners special founders fund v lpwalthampolaris venture partners v lpwalthamteofilo david raadchief business officer lexingtonconley richardsanta rosaconley richardsanta rosaclarke robertlexingtonscott m rocklagedirector lincolnharish sameersanta rosaharish sameersanta rosarocklage scottlexingtonmatthew l shermandirector cambridgegillis stevenlexingtonmcguire terrancelexingtonduke williamlexington dr matthew l sherman joins pulmatrix’s board of directors dr matthew l sherman joins pulmatrixs board of directors dr shermans extensive experience in developing drugs in oncology and other therapeutic areas will help pulmatrix target more diseases potentially including cancer news provided by pulmatrix inc oct    et share this article lexington mass oct   prnewswire  pulmatrix inc nasdaq pulm a pharmaceutical company developing innovative inhaled drugs announced today that the company has appointed matthew l sherman md executive vice president and chief medical officer of acceleron pharma inc a clinical stage biopharmaceutical company as a new member to its board of directors dr sherman has extensive experience in drug development before joining acceleron in  he was head of clinical research and regulatory affairs at synta pharmaceuticals now madrigal pharmaceuticals inc and leader of clinical development in both oncology and hematology at wyeth previously he also held leadership positions at genetics institute in the pharmaceutical industry one of our main goals is to make a difference in the lives of patients said dr sherman being on the board of pulmatrix with its groundbreaking dry powder drug delivery technology offers me another great opportunity to realize that goal dr sherman will offer invaluable help as we bring our drugs for copd for fighting fungal infections in cystic fibrosis patients and for idiopathic pulmonary fibrosis to market said pulmatrix chief executive officer robert w clarke phd his special knowledge of oncology and hematology drugs will also enable us to move more quickly to develop inhaled drugs in other therapeutic areas perhaps including cancer using our technology platform dr sherman is board certified in medical oncology and internal medicine and held various clinical positions at harvard medical school with corresponding hospital appointments at the danafarber cancer institute and brigham and womens hospital  about pulmatrix        pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease using its patented isperse™ technology the companys proprietary product pipeline is focused on advancing treatments for lung diseases including  opportunities in major pulmonary diseases through collaborations like pur a branded generic in clinical development for chronic obstructive pulmonary disease copd and pur an inhaled antifungal that could benefit severe asthmatics and patients with rare disease like cystic fibrosis  pulmatrixs product candidates are based on isperse™ its proprietary dry powder delivery platform which seeks to improve therapeutic delivery to the lungs by maximizing local concentrations and reducing systemic side effects to improve patient outcomes forwardlooking statements  certain statements in this press release that are forwardlooking and not statements of historical fact are forwardlooking statements within the meaning of the safe harbor provisions of the private securities litigation reform act of  the company cautions that such statements involve risks and uncertainties that may materially affect the companys results of operations such forwardlooking statements are based on the beliefs of management as well as assumptions made by and information currently available to management actual results could differ materially from those contemplated by the forwardlooking statements as a result of certain factors including but not limited to the ability to establish that potential products are efficacious or safe in preclinical or clinical trials the ability to establish or maintain collaborations on the development of therapeutic candidates the ability to obtain appropriate or necessary governmental approvals to market potential products the ability to obtain future funding for developmental products and working capital and to obtain such funding on commercially reasonable terms the companys ability to manufacture product candidates on a commercial scale or in collaborations with third parties changes in the size and nature of competitors the ability to retain key executives and scientists and the ability to secure and enforce legal rights related to the companys products including patent protection a discussion of these and other factors including risks and uncertainties with respect to the company is set forth in the companys annual report on form k filed by the company with the securities and exchange commission on march   the company disclaims any intention or obligation to revise any forwardlooking statements whether as a result of new information future events or otherwise except as required by law investor contact                                            robert clarke ceo                                                                                                                             rclarkepulmatrixcom                                 william duke cfo     wdukepulmatrixcom chris brinzey westwicke partners     irpulmatrixcom logo  httpphotosprnewswirecomprnhlogo to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesdrmatthewlshermanjoinspulmatrixsboardofdirectorshtml source pulmatrix inc related links httpwwwpulmatrixcom oct    et preview pulmatrix will present promising new data at the north american cystic fibrosis conference on october   sep    et preview pulmatrix highlights recent report predicting rapid growth for inhaled drug delivery methods my news release contains wide tables view fullscreen also from this source jun    et amit d munshi joins pulmatrixs board of directors jun    et pulmatrix licenses novel drug candidates from respivert ltd a explore more news releases in similar topics health care  hospitals medical pharmaceuticals pharmaceuticals personnel announcements you just read dr matthew l sherman joins pulmatrixs board of directors news provided by pulmatrix inc oct    et share this article looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search matthew l sherman md  cambridge ma  company information products resources my account talk to a db advisor  business directory ma cambridge offices and clinics of medical doctors offices and clinics of medical doctors matthew l sherman md m matthew l sherman md claim this business  cambridgepark dr cambridge ma  get directions   business info founded  incorporated annual revenue  employee count  industries offices and clinics of medical doctors contacts matthew sherman contact business your email address subject message send message company summary since  the company has been providing offices and clinics of medical doctors verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   m view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved matthew l sherman  lake elsinore ca  intelius sign in we found matthew l sherman in lake elsinore ca matthew l sherman intelius found that matthew l sherman is a male between  and  years old from lake elsinore ca we have connected them to  addresses  phones and  relatives or associates get report now age matthew l sherman is in his s matthew has lived in lake elsinore ca brooklyn ny rancho santa margarita ca matthews relatives anne sherman joyce sherman scott sherman wendy sherman matthew l sherman gendermale get report now want to know more about matthew get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about matthew or use our people search engine to find others get background check on matthew l sherman get a criminal check on matthew l sherman get a public record report on matthew l sherman get a people search report on matthew l sherman matthew l shermans contact information known cities lived in find out where matthew l sherman has lived as well as matthew l shermans phone numbers and email addresses matthew l sherman has lived in  states california address for matthew l sherman  g s lake elsinore ca has lived in lake elsinore ca brooklyn ny get full address report phone numbers associated with matthew l sherman    laguna niguel ca    mission viejo ca    mission viejo ca get full phone report email addresses associated with matthew l sherman get email report matthew l shermans social network and potential email matches find out potential social network profiles and potential email usernamed for matthew l sherman matthew l shermans known social networks and potential email matches find all of matthew l shermans social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches matthew sherman username matches matthewsherman shermanmatthew matthewsherman shermanmatthew matthewsherman shermanmatthew matthewsherman shermanmatthew msherman popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches m sherman intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here dr matthew l sherman joins pulmatrixs board of directors  marketwatch x tweet share this bulletin get news bulletins by email bulletin heres whom a us president can and cannot pardon » investor alert new york markets close in market snapshot winners and losers x tweet share this bulletin get news bulletins by email bulletin us existinghome sales fall in june » press release oct    am edt dr matthew l sherman joins pulmatrixs board of directors dr shermans extensive experience in developing drugs in oncology and other therapeutic areas will help pulmatrix target more diseases potentially including cancer lexington mass oct   prnewswire   pulmatrix inc  quoteszigmancomposite pulm   a pharmaceutical company developing innovative inhaled drugs announced today that the company has appointed matthew l sherman md  executive vice president and chief medical officer of acceleron pharma inc  a clinical stage biopharmaceutical company as a new member to its board of directors  dr sherman has extensive experience in drug development before joining acceleron in  he was head of clinical research and regulatory affairs at synta pharmaceuticals now madrigal pharmaceuticals inc  and leader of clinical development in both oncology and hematology at wyeth previously he also held leadership positions at genetics institute in the pharmaceutical industry one of our main goals is to make a difference in the lives of patients said dr sherman being on the board of pulmatrix with its groundbreaking dry powder drug delivery technology  offers me another great opportunity to realize that goal dr sherman will offer invaluable help as we bring our drugs for copd for fighting fungal infections in cystic fibrosis patients and for idiopathic pulmonary fibrosis to market said pulmatrix chief executive officer robert w clarke phd  his special knowledge of oncology and hematology drugs will also enable us to move more quickly to develop inhaled drugs in other therapeutic areas perhaps including cancer using our technology platform  dr sherman is board certified in medical oncology and internal medicine and held various clinical positions at harvard medical school with corresponding hospital appointments at the danafarber cancer institute and brigham and womens hospital  about pulmatrix        pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease using its patented isperse™ technology the companys proprietary product pipeline is focused on advancing treatments for lung diseases including  opportunities in major pulmonary diseases through collaborations like pur a branded generic in clinical development for chronic obstructive pulmonary disease copd and pur an inhaled antifungal that could benefit severe asthmatics and patients with rare disease like cystic fibrosis  pulmatrixs product candidates are based on isperse™ its proprietary dry powder delivery platform which seeks to improve therapeutic delivery to the lungs by maximizing local concentrations and reducing systemic side effects to improve patient outcomes forwardlooking statements  certain statements in this press release that are forwardlooking and not statements of historical fact are forwardlooking statements within the meaning of the safe harbor provisions of the private securities litigation reform act of  the company cautions that such statements involve risks and uncertainties that may materially affect the companys results of operations such forwardlooking statements are based on the beliefs of management as well as assumptions made by and information currently available to management actual results could differ materially from those contemplated by the forwardlooking statements as a result of certain factors including but not limited to the ability to establish that potential products are efficacious or safe in preclinical or clinical trials the ability to establish or maintain collaborations on the development of therapeutic candidates the ability to obtain appropriate or necessary governmental approvals to market potential products the ability to obtain future funding for developmental products and working capital and to obtain such funding on commercially reasonable terms the companys ability to manufacture product candidates on a commercial scale or in collaborations with third parties changes in the size and nature of competitors the ability to retain key executives and scientists and the ability to secure and enforce legal rights related to the companys products including patent protection a discussion of these and other factors including risks and uncertainties with respect to the company is set forth in the companys annual report on form k filed by the company with the securities and exchange commission on march   the company disclaims any intention or obligation to revise any forwardlooking statements whether as a result of new information future events or otherwise except as required by law investor contact                                             robert clarke ceo                                                                                                                             rclarkepulmatrixcom                                  william duke cfo     wdukepulmatrixcom chris brinzey westwicke partners     irpulmatrixcom logo  httpphotosprnewswirecomprnhlogo to view the original version on pr newswire visit httpwwwprnewswirecomnewsreleasesdrmatthewlshermanjoinspulmatrixsboardofdirectorshtml source pulmatrix inc copyright c  pr newswire all rights reserved quoteszigmancomposite add to watchlist pulm pulmatrix inc us  us nasdaq     volume  july   a pe rationa dividend yieldna market cap million rev per employeena most popular  americans in this field have the highest rate of divorce by age   ‘game of thrones’ the four biggest takeaways from stormborn’  oj simpson made over  while in prison and won’t have to give any of it to the goldman family  futures movers oil prices advance as opec meeting unfolds  your next online order could be picked out by a robot find a broker partner center » featured stories seeing america again through new eyes how to dig yourself out of debt move over tesla karma unveils its hybrid sports car the salary you need to afford a home in these  cities why opec will never cut production again log in  am edt july   marketstatecountryus new york open marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aexistinghome sales fall in june as market retrenches after hot spring season a‘game of thrones’ this computer model predicts who will be killed off — or survive awho president trump can pardon and who he can’t aus dollar slightly extends gains after housing data asp  down  at  aus stocks hold modest losses after housing data anasdaq composite flat at  adow industrials off  at  atreasury yields edge lower after existing home sales aexistinghome sales at  million saar aexistinghome sales fall  in june realtors say amanufacturing pmi hits fourmonth high in july a‘game of thrones’ the four biggest takeaways from stormborn’ abreakingdow slumps as wall street focuses on earnings fed ahead ahere are key passages from kushner’s testimony aoj simpson made over  while in prison and won’t have to give any of it to the goldman family athese cashstrapped couples want total strangers to pay for their weddings athe met installs a threestoryhigh painting aihs markit services pmi unchanged at  in july aihs markit manufacturing pmi rises to  in july from  loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  page not found  thestreet action alerts plus access aapjim cramers best stocks for charitable trust portfoliomost recent trade alert investing rules trading commandments real money access rm rules of investingjim cramers best stocks for  commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use  thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under  top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street page not found sorry the page youre looking for is not available you might want to try our homepage our most popular stories  thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers matthew l sherman  norwood ma  intelius sign in we found matthew l sherman in norwood ma matthew l sherman intelius found that matthew l sherman is between  and  years old from norwood ma we have connected them to  address  phone and  relatives or associates get report now age matthew l sherman is in his s matthew has lived in norwood ma matthews relatives megan sherman james sherman leslie sherman matthew l sherman zodiac signvirgo get report now want to know more about matthew get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about matthew or use our people search engine to find others get background check on matthew l sherman get a criminal check on matthew l sherman get a public record report on matthew l sherman get a people search report on matthew l sherman matthew l shermans contact information known cities lived in find out where matthew l sherman has lived as well as matthew l shermans phone numbers and email addresses matthew l sherman has lived in  states massachusetts address for matthew l sherman  a d norwood ma has lived in norwood ma get full address report phone numbers associated with matthew l sherman    norwood ma get full phone report email addresses associated with matthew l sherman get email report matthew l shermans social network and potential email matches find out potential social network profiles and potential email usernamed for matthew l sherman matthew l shermans known social networks and potential email matches find all of matthew l shermans social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches matthew sherman username matches matthewsherman shermanmatthew matthewsherman shermanmatthew matthewsherman shermanmatthew matthewsherman shermanmatthew msherman popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches m sherman intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here dr matthew l sherman joins pulmatrixs board of directors support   newswire  home  log in boards stocks commodities forex cryptocurrency the lounge hot breakout boards ihub my stocks activity ticker buzz cloud most read most posted most followed members recent news active boards site stats new boards cannabis stocks tools data tools  charts trader alerts trades portfolio top lists price  news alerts commodities markets in d newswire more tools  newsletters my image gallery advanced search videos all news stock screener news filter live charts live news live desktop forex prices commodities etf center educational channel personal finance qa streamer level  follow feed quotechartlevel tradesnewsfinancialshistoricaltechnical analysismessage boardpulmatrix inc mm nasdaq dr matthew l sherman joins pulmatrixs board of directors date    am source  pr newswire us stock  pulmatrix inc mm pulm quote       am dr matthew l sherman joins pulmatrixs board of directorstweet print pulmatrix inc nasdaqpulmhistorical stock chart  year  from jul  to jul  lexington mass oct   prnewswire  pulmatrix inc nasdaq pulm a pharmaceutical company developing innovative inhaled drugs announced today that the company has appointed matthew l sherman md executive vice president and chief medical officer of acceleron pharma inc a clinical stage biopharmaceutical company as a new member to its board of directors dr sherman has extensive experience in drug development before joining acceleron in  he was head of clinical research and regulatory affairs at synta pharmaceuticals now madrigal pharmaceuticals inc and leader of clinical development in both oncology and hematology at wyeth previously he also held leadership positions at genetics institute in the pharmaceutical industry one of our main goals is to make a difference in the lives of patients said dr sherman being on the board of pulmatrix with its groundbreaking dry powder drug delivery technology offers me another great opportunity to realize that goal dr sherman will offer invaluable help as we bring our drugs for copd for fighting fungal infections in cystic fibrosis patients and for idiopathic pulmonary fibrosis to market said pulmatrix chief executive officer robert w clarke phd his special knowledge of oncology and hematology drugs will also enable us to move more quickly to develop inhaled drugs in other therapeutic areas perhaps including cancer using our technology platform dr sherman is board certified in medical oncology and internal medicine and held various clinical positions at harvard medical school with corresponding hospital appointments at the danafarber cancer institute and brigham and womens hospital  about pulmatrix        pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease using its patented isperse™ technology the companys proprietary product pipeline is focused on advancing treatments for lung diseases including  opportunities in major pulmonary diseases through collaborations like pur a branded generic in clinical development for chronic obstructive pulmonary disease copd and pur an inhaled antifungal that could benefit severe asthmatics and patients with rare disease like cystic fibrosis  pulmatrixs product candidates are based on isperse™ its proprietary dry powder delivery platform which seeks to improve therapeutic delivery to the lungs by maximizing local concentrations and reducing systemic side effects to improve patient outcomes forwardlooking statements  certain statements in this press release that are forwardlooking and not statements of historical fact are forwardlooking statements within the meaning of the safe harbor provisions of the private securities litigation reform act of  the company cautions that such statements involve risks and uncertainties that may materially affect the companys results of operations such forwardlooking statements are based on the beliefs of management as well as assumptions made by and information currently available to management actual results could differ materially from those contemplated by the forwardlooking statements as a result of certain factors including but not limited to the ability to establish that potential products are efficacious or safe in preclinical or clinical trials the ability to establish or maintain collaborations on the development of therapeutic candidates the ability to obtain appropriate or necessary governmental approvals to market potential products the ability to obtain future funding for developmental products and working capital and to obtain such funding on commercially reasonable terms the companys ability to manufacture product candidates on a commercial scale or in collaborations with third parties changes in the size and nature of competitors the ability to retain key executives and scientists and the ability to secure and enforce legal rights related to the companys products including patent protection a discussion of these and other factors including risks and uncertainties with respect to the company is set forth in the companys annual report on form k filed by the company with the securities and exchange commission on march   the company disclaims any intention or obligation to revise any forwardlooking statements whether as a result of new information future events or otherwise except as required by law investor contact                                            robert clarke ceo                                                                                                                             rclarkepulmatrixcom                                 william duke cfo     wdukepulmatrixcom chris brinzey westwicke partners     irpulmatrixcom logo  httpphotosprnewswirecomprnhlogo to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesdrmatthewlshermanjoinspulmatrixsboardofdirectorshtml source pulmatrix inc copyright  pr newswire latest pulm messages view more posts remove from favorites add to favorites  message board see more message board posts your recent history lse gkp gulf keyst lse qpp quindell ftse ukx ftse  lse iof iofina fx gbpusd uk sterlin stocks youve viewed will appear in this box letting you easily return to quotes youve seen previouslyregister now to create your own custom streaming stock watchlist nyse amex and asx quotes are delayed by at least  minutesall other quotes are delayed by at least  minutes unless otherwise stated